AbbVie Updates Exec Team, Creates A Separate Aesthetics Business Unit

The only addition to AbbVie’s leadership after it closes the $63bn acquisition of Allergan will be Carrie Strom, who will lead the Allergan Aesthetics business.

Close up of hands of cosmetologist making botox injection in female face — Allergan's Botox-led aesthetics franchise is a blockbuster business. • Source: Shutterstock

AbbVie Inc. will keep Allergan PLC’s market-leading medical aesthetics business in the hands of Allergan employees who know how to develop and market products in this unique biopharmaceutical and medical device category after the big pharma closes its $63bn acquisition of the specialty firm in the first quarter of 2020.

Allergan senior vice president of US medical aesthetics Carrie Strom will become a senior vice present at AbbVie and president...